Companies we
believe in.
AI-powered blood tests to detect and monitor liver disease (MASLD/NASH) with greater speed and accuracy than traditional methods — enabling earlier intervention before irreversible damage occurs.
AI-driven electrocardiogram analysis that rapidly and accurately detects cardiac conditions, enabling earlier intervention and better patient outcomes at the point of care.
AI-powered computer vision to contactlessly monitor vital signs and detect patient deterioration — no wires, no cuffs, no electrodes. Founded by the chief of anesthesiology at the San Francisco VA.
AI-powered cardiovascular copilot using physiological modeling and data science to predict and prevent hemodynamic instability in surgical and critical care — enabling clinicians to intervene before complications occur.
AI-enabled robotic system giving physicians real-time, teleoperated access inside the MRI scanner during cancer biopsies and ablations — enabling sub-millimeter targeting of tumors three times smaller than current methods can reach.